journal article·2014-05

Controlling chitosan-based encapsulation for protein and vaccine delivery

Bhanu prasanth Koppolu, Sean G. Smith, Sruthi Ravindranathan, Srinivas Jayanthi, Thallapuranam K. Suresh Kumar, David A. Zaharoff

Biomaterials· Volume 35· Issue 14
Publisher page

Abstract

Chitosan-based nano/microencapsulation is under increasing investigation for the delivery of drugs, biologics and vaccines. Despite widespread interest, the literature lacks a defined methodology to control chitosan particle size and drug/protein release kinetics. In this study, the effects of precipitation-coacervation formulation parameters on chitosan particle size, protein encapsulation efficiency and protein release were investigated. Chitosan particle sizes, which ranged from 300 nm to 3 μm, were influenced by chitosan concentration, chitosan molecular weight and addition rate of precipitant salt. The composition of precipitant salt played a significant role in particle formation with upper Hofmeister series salts containing strongly hydrated anions yielding particles with a low polydispersity index (PDI) while weaker anions resulted in aggregated particles with high PDIs. Sonication power had minimal effect on mean particle size, however, it significantly reduced polydispersity. Protein loading efficiencies in chitosan nano/microparticles, which ranged from 14.3% to 99.2%, were inversely related to the hydration strength of precipitant salts, protein molecular weight and directly related to the concentration and molecular weight of chitosan. Protein release rates increased with particle size and were generally inversely related to protein molecular weight. This study demonstrates that chitosan nano/microparticles with high protein loading efficiencies can be engineered with well-defined sizes and controllable release kinetics through manipulation of specific formulation parameters.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Advancements in Transdermal Drug Delivery · Drug Solubulity and Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (32)

Show source-provided references
1. Chitosan: properties, preparations and application to microparticulate systems10.3109/02652049709006820 ↗
2. Chitosan microspheres as a potential carrier for drugs10.1016/j.ijpharm.2003.12.026 ↗
3. Chitosan as a biomaterial10.3109/10731199009117286 ↗
4. Chitosan matrix for oral sustained delivery of ampicillin10.1016/0142-9612(93)90136-P ↗
5. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency10.1016/S0168-3659(00)00361-8 ↗
6. Chitosan nanoparticles as delivery systems for doxorubicin10.1016/S0168-3659(01)00294-2 ↗
7. Chitosan nanoparticle as protein delivery carrier–systematic examination of fabrication conditions for efficient loading and release10.1016/j.colsurfb.2007.04.009 ↗
8. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles10.1016/S0378-5173(02)00548-3 ↗
9. Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery10.1023/B:PHAM.0000022414.17183.58 ↗
10. Immune stimulating activity of two new chitosan containing adjuvant formulations10.1016/S0264-410X(00)00248-6 ↗
11. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination10.1016/j.vaccine.2006.11.034 ↗
12. The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells10.1016/j.biomaterials.2012.11.066 ↗
13. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan10.1016/S0168-3659(99)00285-0 ↗
14. Effect of the size of biodegradable microparticles on drug release: experiment and theory10.1016/j.jconrel.2004.01.011 ↗
15. Controlled insulin release from chitosan microparticles
16. Preparation and characterization of chitosan microparticles intended for controlled drug delivery10.1016/S0378-5173(02)00487-8 ↗
17. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches10.1016/S0142-9612(00)00231-3 ↗
18. Formulation factors in preparing BTM-chitosan microspheres by spray drying method10.1016/S0378-5173(02)00164-3 ↗
19. Preparation and charecterization of chitosan microspheres as drug carrier for prednisolone sodium phospate as model for anti-inflammatory drugs10.1016/0168-3659(95)00129-8 ↗
20. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery10.1211/jpp.60.12.0004 ↗
21. Molecular parameters of chitosans depolymerized with the aid of papain10.1016/0144-8617(95)00147-6 ↗
22. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins10.1021/jf801111c ↗
23. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery10.1016/j.colsurfb.2005.06.001 ↗
24. Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake10.1002/jbm.a.34153 ↗
25. Controlled release of interleukin-2 from chitosan microspheres10.1002/jps.10122 ↗
26. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo10.1016/S0378-5173(02)00486-6 ↗
27. Ultrasonication of chitosan and chitosan nanoparticles10.1016/S0378-5173(03)00408-3 ↗
28. Different molecular weight chitosan microspheres: influence on drug loading and drug release10.3109/03639049809082726 ↗
29. The Hofmeister series: salt and solvent effects on interfacial phenomena
30. Introductory lecture: interpreting and predicting Hofmeister salt ion and solute effects on biopolymer and model processes using the solute partitioning model10.1039/C2FD20128C ↗
31. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization10.1023/A:1018995124527 ↗
32. Swelling behavior and the release of protein from chitosan pectin composite particles10.1016/S0144-8617(00)00145-4 ↗